Fever of unknown origin, infection of subcutaneous devices, brain abscesses and endocarditis

Nuclear Medicine Communications

Volumn 27, Issue 3, 2006, Pages 213-222

  Cascini, Giuseppe Lucio ^a   De Palma, Diego ^b   Matteucci, Federica ^c   Biggi, Alberto ^c   Rambaldi, Pier Francesco ^c   Signore, Alberto ^c   Mansi, Luigi ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

FDG PET scan; Fever of unknown origin; Gallium scan; Leucocyte scintigraphy; Occult infection

Indexed keywords

ALGORITHM; BRAIN ABSCESS; CLINICAL TRIAL; COMORBIDITY; ENDOCARDITIS; HUMAN; INFECTION; META ANALYSIS; PYREXIA IDIOPATHICA; REVIEW; SCINTISCANNING; BIOPSY TECHNIQUE; BLOOD TESTIS BARRIER; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; LEUKOCYTE; MEDICAL INSTRUMENTATION; MEDICAL LITERATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PUBLICATION; SYSTEMATIC REVIEW; TISSUE CULTURE; TREATMENT INDICATION;

ALGORITHMS; BRAIN ABSCESS; CLINICAL TRIALS; COMORBIDITY; ENDOCARDITIS; FEVER OF UNKNOWN ORIGIN; HUMANS; PROSTHESIS-RELATED INFECTIONS;

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

EID: 33646679139     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200603000-00003     Document Type: Article

References (97)

1. Durak DT. Fever of unknown origin. In: Mackoviac PA, editor. Fever. Basic mechanisms and management. 2nd ed. Philadelphia: Lippincott-Raven; 1997. pp. 237-249.
2. de Kleijn EM, van Lier HJ, van der Meer JW. Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine (Baltimore) 1997; 76:401-414.
3. Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 2003; 163:545-551.
4. MacSweeney JE, Peters AM, Lavender JP. Indium labelled leukocyte scanning in pyrexia of unknown origin. Clin Radiol 1990; 42:414-417.
5. Tudor GR, Finlay DB, Belton I. The value of indium-111-labelled leukocyte imaging and ultrasonography in the investigation of pyrexia of unknown origin. Br J Radiol 1997; 70:918-922.
6. Vanninen E, Korppi M, Bergstrom KA, Lansimies E. Detection of focal inflammation with Tc99m-HMPAO labeled leukocytes in children. Clin Nucl Med 1993; 18:570-572.
7. Sfakianakis GN, Al-Sheilik W, Heal A, Rodman G, Zeppa R, Serafini A. Comparison of scintigraphy with In111-leukocytes and Ga-67 in the diagnosis of occult sepsis. J Nucl Med 1982; 23:618-626.
8. de Kleijn EM, Oyen WJ, Corstens FH, van der Meer JW. Utility of indium-111-labeled polyclonal immunoglobulin G scintigraphy in fever of unknown origin. The Netherlands FUO Imaging Group. J Nucl Med 1997; 38:484-489.
9. Becker W, Dolkemeyer U, Gramatzki M, Schneider MU, Scheele J, Wolf F. Use of immunoscintigraphy in the diagnosis of fever of unknown origin. Eur J Nucl Med 1993; 20:1078-1083.
10. Oyen WJ, Mansi L. FDG-PET in infectious and inflammatory disease. Eur J Nucl Med Mol Imaging 2003; 30:1568-1570.
11. Buscombe JR, Oyen WJ, Corstens FH, Ell PJ, Miller RF. Localization of infection in HIV antibody positive patients with fever. Comparison of the efficacy of Ga-67 citrate and radiolabeled human IgG. Clin Nucl Med 1995; 20:334-339.
12. Lin WY, Chao TH, Wang SJ. Clinical features and gallium scan in the detection of post-surgical infection in the elderly. Eur J Nucl Med Mol Imaging 2002; 29:371-375.
13. McNeil BJ, Sanders R, Alderson PO, Hessel SJ, Finberg H, Siegelman SS, et al. A prospective study of computed tomography, ultrasound, and gallium imaging in patients with fever. Radiology 1981; 139:647-653.
14. Syrjala MT, Valtonen V, Liewendahl K, Myllyla G. Diagnostic significance of indium-111 granulocyte scintigraphy in febrile patients. J Nucl Med 1987; 28:155-160.
15. Kjaer A, Lebech AM. Diagnostic value of (111)In-granulocyte scintigraphy in patients with fever of unknown origin. J Nucl Med 2002; 43:140-144.
16. Davies SG, Garvie NW. The role of indium-labelled leukocyte imaging in pyrexia of unknown origin. Br J Radiol 1990; 63:850-854.
17. Reynolds JH, Graham D, Smith FW. Imaging inflammation with Tc99m HMPAO labelled leucocytes. Clin Radiol 1990; 42:195-198.
18. Baldwin JE, Wraight EP. Indium labelled leukocyte scintigraphy in occult infection: a comparison with ultrasound and computed tomography. Clin Radiol 1990; 42:199-202.
19. Vorne M, Soini I, Lantto T, Paakkinen S. Technetium-99m HMPAO labeled leukocytes in detection of inflammatory lesions: comparison with gallium 67 citrate. J Nucl Med 1989; 30:1332-1336.
20. Roddie ME, Peters AM, Danpure HJ, Osman S, Henderson BL, Lavander JP, et al. Inflammation: imaging with Tc99m HMPAO labeled leukocytes. Radiology 1988; 16:767-772.
21. Minoja G, Chiaranda M, Fachinetti A, Raso M, Dominioni L, Torre D, De Palma D. The clinical use of 99m-Tc-labeled WBC scintigraphy in critically ill surgical and trauma patients with occult sepsis. Intensive Care Med 1996; 22:867-871.
22. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun 2001; 22:779-783.
23. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, Mortelmans L. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32:191-196.
24. Ichiya Y, Kuwabara Y, Sasaki M, Yoshida T, Akashi Y, Murayama S, et al. PET-FDG in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med 1996; 10:185-191.
25. Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 2000; 27:1617-1625.
26. O'Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997; 38:1575-1583.
27. Gratz S, Behr TM, Herrmann A, Meller J, Conrad M, Zappel H, Becker W. Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin. Nucl Med Commun 1998; 19:1037-1045.
28. Meller J, Ivancevic V, Conrad M, Gratz S, Munz DL, Becker W. Clinical value of immunoscintigraphy in patients with fever of unknown origin. J Nucl Med 1998; 39:1248-1253.
29. Oyen WJ, Claessens RA, van der Meer JW, Rubin RH, Strauss HW, Corstens FH. Indium-111-labeled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci. Clin Infect Dis 1992; 14:1110-1118.
30. Kjaer A, Lebech AM, Eigtved A, Hojgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004; 31:622-626.
31. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004; 31:29-37.
32. Buscombe J, Signore A. FDG-PET in infectious and inflammatory disease. Eur J Nucl Med Mol Imaging 2003; 30:1571-1573.
33. Lewis AB, Hayes DL, Holmes DR Jr, Vlietstra RE, Pluth JR, Osborn MJ. Update on infections involving permanent pacemakers. J Thorac Cardiovasc Surg 1985; 89:785.
34. Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity. A clinical survey. Am J Phys Med Rehabil 2000; 79:536-541.
35. Cerqueira MD. Detection of cardiovascular infections with radiolabeled leukocytes. J Nucl Med 1992; 33:1493-1495.
36. Aldrete JA, Williams SK. Infections from extended epidural catheterization in ambulatory patients [abstract]. Reg Anesth Pain Med 1998; 23:491-495.
37. Naumann C, Erdine S, Koukousakis A, Van Buyten JP, Schuchard M. Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management. Neuromodulation 1999; 2:92-107.
38. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Strijewski ME, Corey GR, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004; 147:582-586.
39. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133:604-608.
40. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, et al. Systemic infections related to endocarditis on pacemaker leads. Circulation 1997; 95:2098-2107.
41. Cohen MI, Bush DM, Gaynor JW, Vetter VL, Tanel RE, Rhodes L. Pediatric pacemaker infections: twenty years of experience. J Thorac Cardiovasc Surg 2002; 124:821-827.
42. Rundstrom H, Kennegren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 years in Goteborg. Scand J Infect Dis 2004; 36:674-679.
43. Howarth DM, Curteis PG, Gibson S. Infected cardiac pacemaker wires demonstrated by 99mTc labeled white blood cell scintigraphy. Clin Nucl Med 1998; 23:74-76.
44. Ramackers JM, Kotzki PO, Couret I, Messner-Pellenc P, Davy JM, Rossi M, et al. The use of 99mTc HMPAO labelled granulocytes with single-photon emission tomography imaging in the detection and follow up of recurrence of infective endocarditis complicating transvenous endocardial pacemaker. Eur J Nucl Med 1995; 22:1351-1354.
45. Tange S, Saigusa H, Inaba S. Pacemaker infection with superior vena cava thrombotic obstruction, followed by bacteraemia: a case report [abstract]. Kokyu To Junkan 1991; 39:497-500.
46. Miyata A, Fujiwara T, Fujii S, Kikuchi T, Osada T. Sick sinus syndrome after chemotherapy for malignant lymphoma with a right atrial tumor at initial presentation [abstract]. Rinsho Ketsueki 1998; 39:1190-1193.
47. Senior K. Bacteraemia poses risks for pacemaker patients. Lancet 2001; 358:732.
48. Martinez JG. Pacemaker pocket infection. Pacing Clin Electrophysiol 1999; 22:691-692.
49. Voet JG, Vanderkerckhove YR, Muyldermans LL, Missault LH, Matthys LJ. Pacemaker lead infection: report of three cases and review of the literature. Heart 1999; 81:88-91.
50. Bhadelia RA, Oates E. Early cardioverter defibrillator infection: value of indium 111 leukocyte imaging. Ann Thorac Surg 1997; 63:236-238.
51. Taylor RL, Cohen DJ, Widman LE, Chilton RJ, O'Rourke RA. Infection of an implantable cardioverter defibrillator: management without removal of the device in selected cases. Pacing Clin Electrophysiol 1990; 13:1352-1355.
52. Almassi GH, Olinger GN, Troup PJ, Chapman PD, Goodman LR. Delayed infection of the automatic implantable cardioverter defibrillator. J Thorac Cardiovasc Surg 1988; 95:908-911.
53. Desai PD, Yuille DL. The unsuspected complications of bacterial endocarditis imaged by gallium 67 scanning. J Nucl Med 1993; 34:955-957.
54. Morguet AJ, Munz DL, Ivancevic V, Werner GS, Sandrock D, Bokemeier M, et al. Immunoscintigraphy using 99mTc labelled anti NCA-95 antigranulocyte antibodies as an adjunct to echocardiography in subacute infective endocarditis. J Am Coll Cardiol 1994; 23:1171-1178.
55. Malacarne F, De Paoli Vitali E, Prandini N, Feggi L, Perini L, Cervi PM, et al. Increased uptake of radiolabelled WBC into abdomen of uremic patient on peritoneal dialysis. Adv Periton Dial 1992; 8:39-41.
56. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, et al. Staphylococcus aureus bacteraemia in patients with permanent pacemaker or implantable cardioverter-defibrillators. Circulation 2001; 28:1029-1033.
57. Wickline SA, Fisher KC. Can infections be imaged in implanted devices? [abstract]. ASAIO J 2000; 46:80-81.
58. Victor F, de Place C, Leclerq C, Camus C, Gras D, Le Helloco A, et al. Infections on permanent endocavitary pacemaker leads: diagnostic value of transesophageal echocardiography. Arch Mal Coeur Vaiss 1995; 88:1875-1881.
59. Kelly PA, Wallace S, Tucker B, Hurvitz RJ, Ilvento J, Mirabel GS, et al. Postoperative infection of the automatic implantable cardioverter defibrillator: clinical presentation and the use of gallium scan in diagnosis. Pacing Clin Electrophysiol 1988; 11:1220-1225.
60. Goethals I, Dierckx R, Van Laere K, Van de Wiele C, Signore A. The role of nuclear medicine imaging in routine assessment of infectious brain pathology. Nucl Med Commun 2002; 23:819-826.
61. Rehncrona S, Brismar J, Holtas S. Diagnosis of brain abscesses with 111-indium oxine-labelled leukocytes. Neurosurgery 1985; 16:23-26.
62. Bellotti C, Aragno M, Medina M, Viglietti AL, Olivieri G, Ettorre F, et al. Differential diagnosis of CT-hypodense cranial lesions with indium-111-oxine-labeled leucocytes. J Neurosurg 1986; 64:750-753.
63. Bellotti C, Medina M, Olivieri G, Ettorre F, Barale S, Sturiale C, et al. Cerebral scintigraphy with 111-indium oxine-labelled leukocytes in the differential diagnosis of intracerebral cystic lesions. Acta Neurochir Suppl 1988; 42:221-224.
64. Schmidt K, Rasmussen J, Frederiksen P, Kok-Jensen C, Pedersen N. Indium-111-granulocyte scintigraphy in brain abscess diagnosis: limitations and pitfalls. J Nucl Med 1990; 31:1121-1127.
65. Palestro C, Swyer A, Kim C, Muzinic M, Goldsmith S. Role of In-111 labeled leucocytes scintigraphy in the diagnosis of intracerebral lesions. Clin Nucl Med 1991; 16:305-308.
66. Grimstad IA, Hirschberg H, Rootwelt K. 99mTc-hexamethylpropylene amine oxime leucocyte scintigraphy and C-reactive protein levels in the differential diagnosis of brain abscesses. J Neurosurg 1992; 77:732-736.
67. Kim DG, Lee J, Lee DS, Lee MC, Choi KS, Han DH. 99mTc-HMPAO labelled leukocyte SPECT in intracranial lesions. Surg Neurol 1995; 44:338-345.
68. Sandrock D, Verheggen R, Helwig AT, Munz DL, Makakis E, Emrich D. Immunoscintigraphy in the detection of brain abscesses. Nucl Med Commun 1996; 17:311-316.
69. Spinelli F, Sara R, Milella M, Ruffini L, Sterzi R, Causarano IR, Sberna M. Technetium-99m hexamethylpropylene amine oxime leucocyte scintigraphy in the differential diagnosis of cerebral abscesses. Eur J Nucl Med 2000; 27:46-49.
70. Medina M, Viglietti AL, Gozzoli L, Lucano A, Ravasi L, Lucignani G, Camuzzini G. Indium-111 labelled white blood cell scintigraphy in cranial and spinal septic lesions. Eur J Nucl Med 2000; 27:1473-1480.
71. Berlin JA, Abrutyn E, Strom BL, Kinman JL, Levison ME, Korzeniowski OM, et al. Incidence of infective endocarditis in the Delaware Valley, 1988-1990. Am J Cardiol 1995; 76:933-936.
72. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore) 1995; 74:324-339.
73. Watanakunakorn C, Burkert T. Infective endocarditis at a large community teaching hospital, 1980-1990: a review of 210 episodes. Medicine (Baltimore) 1993; 72:90-102.
74. Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis 2000; 30:374-379.
75. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345:1318-1330.
76. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis; utilization of specific echocardiographic findings. Am J Med 1994; 96:200-209.
77. Perez-Vasquez A, Farinas MC, Garcia-Palomo JD, Bernal JM, Revuelta JM, Gonzalez-Macias J. Evaluation of the Duke criteria in 93 episodes of prosthetic valve endocarditis: could sensitivity be improved? Arch Intern Med 2000; 160:1185-1191.
78. Dodds GA, Sexton DJ, Durack DT, Bashore TM, Corey GR, Kisslo J. Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol 1996; 77:403-407.
79. Shively BK, Gurule FT, Roldan CA, Leggett JM, Schiller NB. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991; 18:391-397.
80. Werner GS, Schultz R, Fuchs JB, Andreas S, Prange H, Ruschewski W, et al. Infective endocarditis in the elderly in the era of transesophageal echocardiography: clinical features and prognosis compared with younger patients. Am J Med 1996; 100:90-97.
81. Heidenreich PA, Masoudi FA, Maini B, Chou TM, Foster E, Schiller NB, et al. Echocardiography in patients with suspected endocarditis: a cost-effective analysis. Am J Med 1999; 107:198-208.
82. Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998; 98:2936-2948.
83. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36:1301-1306.
84. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
85. Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Gunasekera R, et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13:829-831.
86. Sugawara Y, Gutowski TD, Fisher SJ, Brown RS, Wahl RL. Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. Eur J Nucl Med 1999; 26:333-341.
87. Yen R-F, Chen Y-C, Wu YW, Pan MH, Chang SC. Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: a preliminary report. Acad Radiol 2004; 11:316-321.
88. Ivancevic V, Munz DL. Nuclear medicine imaging of endocarditis. Q J Nucl Med 1999; 43:93-99.
89. Morguet AJ, Munz DL, Ivancevic V, Werner GS, Kreuzer H. The clinical importance of scintigraphy with the murine monoclonal antigranulocyte antibody BW 250/183 for the diagnosis of prosthesis-related endocarditis. Dtsch Med Wochenschr 1995; 120:861-866.
90. Gratz S, Raddatz D, Hagenah G, Behr T, Behe M, Becker W. 99mTc-labelled antigranulocyte monoclonal antibody FAB′ fragments versus echocardiography in the diagnosis of subacute infective endocarditis. Int J Cardiol 2000; 75:75-84.
91. Munz DL, Morguet AJ, Sandrock D, Heim A, Sold G, Figulla HR et al. Radioimmunoimaging of subacute infective endocarditis using a technetium-99m monoclonal granulocyte-specific antibody. Eur J Nucl Med 1991; 18:977-980.
92. Becker W, Dolkemeyer U, Gramatzki M, Schneider MU, Scheele J, Wolf F. Use of immunoscintigraphy in the diagnosis of fever of unknown origin. Eur J Nucl Med 1993; 20:1078-1083.
93. Melvin ET, Berger M, Lutzker LG, Goldberg E, Mildvan D. Noninvasive methods for detection of valve vegetations in infective endocarditis. Am J Cardiol 1981; 47:271-278.
94. Borst U, Becker W, Maisch B, Borner W, Kochsiek K. Clinical and prognostic effect of a positive granulocyte scan in infective endocarditis. Clin Nucl Med 1993; 18:35-39.
95. Cerqueira MD, Jacobson AF. Indium-111 leukocyte scintigraphic detection of myocardial abscess formation in patients with endocarditis. J Nucl Med 1989; 30:703-706.
96. Wiseman J, Rouleau J, Rigo P, Strauss HW, Pitt B. Gallium-67 myocardial imaging for the detection of bacterial endocarditis. Radiology 1976; 120:135-138.
97. Kohata T, Ono Y, Kamiya T, Nishimura T, Takamiya M, Yagihara T. 67Ga imaging in patients with infective endocarditis after surgery for congenital heart disease. Kaku Igaku 1991; 28:1283-1288.